Literature DB >> 1938222

Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients.

M Kuźniewski1, W Sułowicz, J Lisiewicz.   

Abstract

In 10 patients (8 men and 2 women) aged 28 to 58 years (mean 44.4 years) treated by repeated haemodialysis due to end-stage renal failure, the bleeding time, whole-blood coagulation time, one-stage prothrombin time, thrombin time of plasma, activated partial thromboplastin time (APTT), fibrinogen level and euglobulin lysis time have been determined (1) during a 4-hour haemodialysis using heparin as an antithrombotic agent, and (2) one week later in the course of another haemodialysis using prostacyclin-heparin. The values for any of the above parameters with both anticoagulant treatment types did not differ. Plasma fibrinogen level after haemodialysis was significantly lower after administration of heparin alone as compared with the group treated by prostacyclin-heparin infusion. During haemodialysis performed with prostacyclin-heparin infusion, activation of the blood fibrinolytic system was manifested by a significant shortening of euglobulin lysis time, observed after 1.5 hours and after the end of haemodialysis. The above phenomenon did not occur when haemodialysis was performed with heparin alone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1938222     DOI: 10.1007/bf02549733

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  33 in total

Review 1.  Antithrombin III and heparin.

Authors:  T W Barrowcliffe; E A Johnson; D Thomas
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

2.  Competitive adsorption of plasma proteins onto polymer surfaces.

Authors:  R G Lee; C Adamson; S W Kim
Journal:  Thromb Res       Date:  1974-03       Impact factor: 3.944

3.  Heparin action.

Authors:  R D Rosenberg
Journal:  Circulation       Date:  1974-04       Impact factor: 29.690

Review 4.  Heparin and platelet function.

Authors:  M B Zucker
Journal:  Fed Proc       Date:  1977-01

5.  Defective ADP-induced platelet factor 3 activation in uremia.

Authors:  H I Horowitz; B D Cohen; P Martinez; M F Papayoanou
Journal:  Blood       Date:  1967-09       Impact factor: 22.113

6.  Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes.

Authors:  R M Lindsay; C R Prentice; J F Davidson; J A Burton; G P McNicol
Journal:  Br Med J       Date:  1972-11-25

7.  Heparin free dialysis: comparative data and results in high risk patients.

Authors:  R J Caruana; R M Raja; J V Bush; M S Kramer; S J Goldstein
Journal:  Kidney Int       Date:  1987-06       Impact factor: 10.612

8.  Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.

Authors:  R M Zusman; R H Rubin; A E Cato; D M Cocchetto; J W Crow; N Tolkoff-Rubin
Journal:  N Engl J Med       Date:  1981-04-16       Impact factor: 91.245

9.  Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

Authors:  P M Mannucci; G Remuzzi; F Pusineri; R Lombardi; C Valsecchi; G Mecca; T S Zimmerman
Journal:  N Engl J Med       Date:  1983-01-06       Impact factor: 91.245

10.  Effects of intravenous infusion of prostacyclin (PGI2) in man.

Authors:  J O'Grady; S Warrington; M J Moti; S Bunting; R Flower; A S Fowle; E A Higgs; S Moncada
Journal:  Prostaglandins       Date:  1980-02
View more
  1 in total

1.  Influence of prostacyclin infusion on haemodialysis efficiency and blood cells.

Authors:  M Kuźniewski; W Sułowicz
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.